Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4800459
Max Phase: Preclinical
Molecular Formula: C40H37N7O3
Molecular Weight: 663.78
Molecule Type: Unknown
Associated Items:
ID: ALA4800459
Max Phase: Preclinical
Molecular Formula: C40H37N7O3
Molecular Weight: 663.78
Molecule Type: Unknown
Associated Items:
Canonical SMILES: COc1ccc(Cn2c(CCc3ccccc3)nnc2[C@@H](Cc2c[nH]c3ccccc23)NC(=O)CNC(=O)/C(C#N)=C/c2ccccc2)cc1
Standard InChI: InChI=1S/C40H37N7O3/c1-50-33-19-16-30(17-20-33)27-47-37(21-18-28-10-4-2-5-11-28)45-46-39(47)36(23-32-25-42-35-15-9-8-14-34(32)35)44-38(48)26-43-40(49)31(24-41)22-29-12-6-3-7-13-29/h2-17,19-20,22,25,36,42H,18,21,23,26-27H2,1H3,(H,43,49)(H,44,48)/b31-22+/t36-/m1/s1
Standard InChI Key: SRTYHQRWBHEEEC-GXPOVIRGSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 663.78 | Molecular Weight (Monoisotopic): 663.2958 | AlogP: 5.72 | #Rotatable Bonds: 14 |
Polar Surface Area: 137.72 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 3 |
#RO5 Violations: 2 | HBA (Lipinski): 10 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 11.69 | CX Basic pKa: 2.03 | CX LogP: 5.49 | CX LogD: 5.49 |
Aromatic Rings: 6 | Heavy Atoms: 50 | QED Weighted: 0.10 | Np Likeness Score: -0.97 |
1. Haj Salah KB,Maingot M,Blayo AL,M'Kadmi C,Damian M,Mary S,Cantel S,Neasta J,Oiry C,Péraldi-Roux S,Fernandez G,Romero GG,Perello M,Marie J,Banères JL,Fehrentz JA,Denoyelle S. (2020) Development of Nonpeptidic Inverse Agonists of the Ghrelin Receptor (GHSR) Based on the 1,2,4-Triazole Scaffold., 63 (19.0): [PMID:32882134] [10.1021/acs.jmedchem.9b02122] |
Source(1):